Medical Congress Intelligence: How AI Helps Pharma Teams Keep Up

Nov 20, 2026 - 23:35
Medical Congress Intelligence: How AI Helps Pharma Teams Keep Up

Pharma teams covering ASCO, ESMO, ASH and other congresses face thousands of abstracts in a few days; this guide explains how AI conference intelligence platforms such as ConfXcel organise that coverage into searchable insight.

Medical Congress Intelligence: How AI Helps Pharma Teams Keep Up

Medical congresses now produce more data in a single week than most pharma teams can read in a month. ESMO 2025 alone accepted 2,926 abstracts, and the 2025 ASH Annual Meeting reported more than 8,200 accepted abstracts. AI conference intelligence platforms, including ConfXcel from XceliSys Consulting, are built to turn that volume into briefings, summaries and a searchable record that several teams can share.

Key takeaways

  • Major congresses are large and growing: ESMO 2025 drew 35,676 attendees, up from 33,830 the year before.
  • Congress coverage works in three stages: preparation before the meeting, fast summaries during it and a searchable archive after it.
  • Field notes, recordings and interviews carry context that public abstracts do not, so they belong in the same record.
  • Competitive Intelligence, Medical Affairs, Market Access and Commercial teams read congress data differently, but all of them benefit from one shared source.
  • Security matters: ask any vendor how data is encrypted, who can access it and what is logged.

Why medical congress coverage has become so hard

The first challenge is scale. According to the European Medical Journal's review of the meeting, ESMO Congress 2025 in Berlin, held from 17 to 21 October 2025, had 35,676 attendees, an all-time high. It received 5,677 abstracts and accepted 2,926 for presentation.

Haematology shows the same pattern. The 2025 ASH Annual Meeting in Orlando, held from 6 to 9 December 2025, drew more than 30,000 attendees and more than 8,200 accepted abstracts, according to the UF Health Cancer Institute.

Oncology's largest meeting is no smaller. The 2025 ASCO Annual Meeting ran from 30 May to 3 June at McCormick Place in Chicago and featured more than 200 sessions, according to UChicago Medicine. Single institutions bring large volumes too: Mayo Clinic said it had 59 Mayo Clinic-authored abstracts at the meeting.

For a pharma team tracking one therapeutic area, each of these numbers means hours of reading, cross-checking and writing. Most of that work happens under time pressure, while the congress is still running and leaders are asking what the new data means.

The old way: scattered notes and spreadsheets

ConfXcel's website says its founding team spent more than a decade working with global biopharma organisations on portfolio strategy, business development and competitive positioning, including coverage of major medical congresses. In that work, the company says, it saw coverage depend on manual notes, fragmented spreadsheets and large analyst teams, with insights often arriving too late to be useful.

This way of working creates three practical problems. Insights stay with the person who wrote them. Different teams write their own versions of the same session. And when a question comes up six months later, nobody can easily find what was said, or who said it.

A single shared source solves much of this. When every team works from the same record, a field note on a poster discussion sits next to the abstract it refers to, and a market access lead can check the same data the competitive intelligence analyst used.

How AI conference intelligence works in three stages

Every congress follows a clear cycle, and good coverage follows it too. ConfXcel, an AI conference intelligence platform for pharma, describes its service in three stages.

  • Before the congress: briefings on chosen therapeutic areas and competitors, so teams arrive knowing which sessions matter.
  • During the congress: presentation summaries, extraction of key endpoints and daily updates while sessions are still running.
  • After the congress: a searchable archive that tracks therapies and data over time, plus transcription of field recordings.

The company says the platform covers ASCO, ASH, EHA, ESMO, AACR and other major congresses. The archive stage becomes more useful every year. With a searchable record, a team can compare how a therapy's data has changed from one meeting to the next, without rebuilding old summaries by hand.

Adding field intelligence to public data

Public abstracts and slides are only part of the picture. Much of the useful context at a congress comes from conversations at posters, questions after talks and interviews with experts.

ConfXcel says teams can upload their own field notes, recordings and interviews, which are transcribed and stored alongside public congress material. In practice, an off-script comment from a session can then turn up in the same search as the abstract it relates to.

Whatever tool a team uses, the habit is simple. Capture field observations the same day, tag them to the session or product they relate to, and store them where colleagues can search them. Notes kept in personal files are rarely used again.

One source for four teams

Congress data serves several functions, and each asks different questions. According to the company, ConfXcel is built for four teams that commonly work from congress coverage.

  • Competitive Intelligence: tracking rival programmes, trial readouts and how new data positions products within a therapeutic area.
  • Medical Affairs: following the scientific discussion, expert views and remaining evidence gaps.
  • Market Access: watching the endpoints and outcomes that may matter in later value and reimbursement discussions.
  • Commercial: understanding how new data may shape conversations with clinicians.

With one shared source, two teams discussing the same trial start from the same facts. Nobody has to rebuild a summary a colleague has already written, and disagreements become about interpretation, not about what was presented.

Security questions to ask any vendor

Congress coverage often mixes public data with confidential field notes and internal strategy. Any platform that stores this material needs clear security controls.

ConfXcel states that its platform uses AES-256 encryption at rest and TLS 1.2 or higher in transit. The company also describes its setup as SOC 2 Type 2 aligned and SSO ready, with role-based access and audit trails. Buyers with strict requirements should ask any vendor for the documentation that matches their own policies. Useful questions include:

  • How is data encrypted at rest and in transit?
  • Who can see which records, and can access be limited by role?
  • Is every access and change recorded in an audit trail?
  • Does the platform support single sign-on with the company's identity system?
  • What independent audits or reports can the vendor share?

Planning coverage for the next congress

Good coverage starts weeks before the meeting. A simple plan helps teams avoid gaps and duplicated work.

  • Agree on the therapeutic areas, products and competitors that matter most.
  • Assign owners for key sessions, posters and expert conversations.
  • Decide how and where field notes will be shared each day.
  • Set a daily deadline for summaries so leaders see updates while the congress is still running.
  • After the meeting, review what was captured and add it to the long-term archive.

Tools can speed up each step, but the plan decides what gets captured. Teams that agree on priorities early get more value from any platform they use.

What the changing oncology agenda means for congress teams

The topics on congress programmes are changing as well. At the opening of ESMO 2025, the congress's 50th year, AI and digital oncology were key discussion topics, and ESMO planned to release a framework for using large language models in clinical practice, according to pharmaphorum.

The same coverage noted presidential sessions featuring data from Japan and China, and a new generation of antibody-drug conjugates being shown to affect patients with early-stage cancer. For congress teams, more countries and more drug classes mean more sessions to watch and more data to compare.

Planning windows are already open. The 68th ASH Annual Meeting is scheduled for 12 to 15 December 2026 in New Orleans and online, according to the American Society of Hematology, so teams can start briefings well before the first session.

Frequently asked questions

What is a medical congress intelligence platform?

It is a tool that collects, summarises and stores information from medical congresses so pharma and biotech teams can find it quickly. It usually covers preparation before the meeting, summaries during it and an archive afterwards.

Which congresses does ConfXcel cover?

The company says ConfXcel covers ASCO, ASH, EHA, ESMO, AACR and other major congresses. Teams should check the current list before planning their coverage.

Can teams add their own notes and recordings?

Yes, according to the company. Field notes, recordings and interviews can be uploaded, transcribed and stored next to public congress data.

How large are today's major congresses?

ESMO 2025 had 35,676 attendees and accepted 2,926 abstracts, according to the European Medical Journal. The 2025 ASH Annual Meeting drew more than 30,000 attendees and had more than 8,200 accepted abstracts, according to the UF Health Cancer Institute.

About ConfXcel

ConfXcel is an AI-powered conference intelligence platform developed by XceliSys Consulting, which the company says is based in Gurugram, India. It gives pharma and biotech teams pre-conference briefings, daily presentation summaries and a searchable archive of medical congress coverage, and lets them add their own field notes, recordings and interviews. Website: real-time competitive intelligence pharma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Shivam Madaan Media Influencer